Poitiers University Hospital

This study is testing different combinations of medications for older adults (65-80 years) who have newly diagnosed multiple myeloma and cannot undergo a stem cell transplant. Researchers want to see if adding certain drugs to standard treatment helps control the cancer better an…

This study is testing whether a drug called bevacizumab can help people with hereditary hemorrhagic telangiectasia (HHT) who have severe liver problems that are putting extra strain on their heart. It will involve 111 patients in France who are already receiving this drug through…

This small pilot study is testing whether a new computer algorithm can monitor how hard patients are breathing while receiving high-flow oxygen therapy. The goal is to see if this non-invasive method can predict when the oxygen treatment might fail, potentially helping doctors de…